Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The company's genomics platform uses a combination of machine-learning, proprietary signal processing algorithms, and next-generation sequencing to enable the broad and rapid detection of microbial cell-free DNA through a standard blood draw. The Karius test can detect more than 1,250 pathogens and return results within one business day, empowering doctors to rapidly diagnose infections, provide more targeted treatment, and spare patients the pain and risks of invasive biopsies. Clinical evidence is published with multiple studies underway. We are molecular biologists, software engineers, data scientists, clinicians, designers, and commercial experts drawn together by a shared vision to transform global health. We thrive on new challenges and problem-solving and work tirelessly to push the boundaries of next-generation genomic diagnostics and technologies for the benefit of human infectious disease. Join us on Twitter and follow our mission at www.karix.com